“…Although meta-analyses demonstrated that technical and clinical success of SEMS as a palliative aim was 92% to 94% and 88% to 91%, respectively, in patients with CRC, 6,18,19 previous studies showed technical success rate of 42% to 66.7% and clinical success rates of 20% to 25% in patients with ECM. 3,4 One study argued that there was a 77% rate of clinical success in 35 patients with recurrent gynecologic cancer. 20 However, because 14 patients required subsequent surgery for continuous obstruction symptoms, the actual clinical success rate was 57%.…”